Log in to save to my catalogue

Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: proto...

Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: proto...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_701c1c0279bb45f2861c199cba7cbd42

Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis [version 2; peer review: 2 approved with reservations]

About this item

Full title

Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis [version 2; peer review: 2 approved with reservations]

Publisher

England: F1000 Research Limited

Journal title

F1000 research, 2024, Vol.13, p.1017

Language

English

Formats

Publication information

Publisher

England: F1000 Research Limited

More information

Scope and Contents

Contents

Background Muscarinic receptor agonism and positive allosteric modulation is a promising mechanism of action for treating psychosis, not present in most D2R-blocking antipsychotics. Xanomeline, an M1/M4-preferring agonist, has shown efficacy in late-stage clinical trials, with more compounds being investigated. Therefore, we aim to synthesize evide...

Alternative Titles

Full title

Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis [version 2; peer review: 2 approved with reservations]

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_701c1c0279bb45f2861c199cba7cbd42

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_701c1c0279bb45f2861c199cba7cbd42

Other Identifiers

ISSN

2046-1402

E-ISSN

2046-1402

DOI

10.12688/f1000research.155356.2

How to access this item